Biocrates Life Sciences

About:

Biocrates provides enables users to get a snapshot of the physiological state of an organism as determined by certain biological inputs.

Website: http://www.biocrates.com

Twitter/X: biocrates_

Top Investors: MIG Capital, Arax Capital Partners, Global Asset Fund

Description:

Biocrates is a developer of a metabolomics platform designed to support the discovery and validation of biomarkers for complex diseases. The company's metabolomics platform comprises an automated sample preparation workflow integrated with sensitive mass-spectrometric methods and software that controls sample management, data collection, and analysis to identify hundreds of metabolites, enabling physicians to acquire comprehensive metabolic information quickly and reliably.

Total Funding Amount:

$14.1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Innsbruck, Tirol, Austria

Founded Date:

2002-01-01

Contact Email:

sales(AT)biocrates.com

Founders:

Adelbert Roscher, Gunther Bonn

Number of Employees:

11-50

Last Funding Date:

2019-09-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai